Axcelis Technologies, Inc. (ACLS) – What Are Analysts Thinking About This Stock?

Axcelis Technologies, Inc. (NASDAQ:ACLS) has earned a consensus rating of “Hold” from the five brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $148.67.

A number of equities research analysts recently weighed in on the stock. Craig Hallum downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a research note on Friday, August 7th. Weiss Ratings raised Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 16th.

Axcelis Technologies News Summary

Here are the key news stories impacting Axcelis Technologies this week:

• Positive Sentiment: Q3 adjusted EPS was $1.26, ahead of the $1.11 consensus estimate, while revenue of $237.8 million topped the $230.1 million estimate and rose 11.3% year over year. Zacks article
• Positive Sentiment: Q4 guidance was well above analyst expectations: Axcelis forecast EPS of $1.50 versus $1.18 consensus and revenue of $275 million versus $239.3 million. The outlook suggests stronger near-term results than investors had anticipated. Axcelis Q3 results release
• Neutral Sentiment: The earnings-call transcript was published, but the provided article details do not identify additional developments beyond the reported results and guidance. Earnings call transcript
• Neutral Sentiment: Although ACLS shares moved lower, the supplied news points to stronger-than-expected earnings and guidance and provides no clear negative company-specific catalyst to explain the decline.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Wellington Management Group LLP purchased a new position in Axcelis Technologies during the second quarter valued at $13,070,000. The Manufacturers Life Insurance Company grew its holdings in shares of Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after purchasing an additional 477,705 shares in the last quarter. Reinhart Partners LLC. increased its holdings in shares of Axcelis Technologies by 14.2% in the 3rd quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock worth $139,134,000 after buying an additional 131,976 shares during the last quarter. Entropy Technologies LP purchased a new stake in Axcelis Technologies during the first quarter valued at approximately $1,004,000. Finally, Segall Bryant & Hamill LLC boosted its stake in shares of Axcelis Technologies by 96.1% during the 1st quarter. Segall Bryant & Hamill LLC now owns 200,371 shares of the semiconductor company’s stock worth $18,651,000 after purchasing an additional 98,184 shares during the period. 89.98% of the stock is owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Performance

NASDAQ ACLS opened at $90.00 on Friday. The company has a market cap of $2.78 billion, a P/E ratio of 23.57, a PEG ratio of 2.81 and a beta of 1.88. The company has a fifty day simple moving average of $116.08 and a 200 day simple moving average of $122.65. Axcelis Technologies has a 12-month low of $73.60 and a 12-month high of $193.78. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last announced its earnings results on Thursday, November 5th. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.15. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The firm had revenue of $237.78 million during the quarter, compared to analyst estimates of $230.08 million. During the same period last year, the firm posted $1.21 EPS. The business’s revenue was up 11.3% compared to the same quarter last year. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. Sell-side analysts predict that Axcelis Technologies will post 3.39 earnings per share for the current fiscal year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.